Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Medical Laboratory Scientists Working with Blood Samples and Equipment in a Lab Setting
© AdobeStock/AS Studio

Tuberculosis: An immune signature in the blood indicates whether treatment is working

Researchers at the Research Center Borstel, Leibniz Lung Center (FZB) and the German Center for Infection Research (DZIF) have identified a novel whole blood-based immune signature that could improve

Black-and-white electron micrograph of a rod-shaped, dark gray bacterial cell surrounded by a thick layer of light gray filaments.
© Christoph Ernst.

From urinary tract infection to brain abscess: How bacterial subpopulations can spread to distant body sites

Researchers from the University of Cologne, the German Center for Infection Research (DZIF), and the Broad Institute of Harvard and MIT present a remarkable clinical case in the New England Journal of

The gloved hands of a person injecting a vaccine into a woman's arm.
© Alexandru Dobre/stock.adobe.com

COVID-19 vaccines remain effective despite helminth-induced immune modulation

More than a quarter of the world's population is affected by helminth infections, which can profoundly alter the immune system. In a preclinical study, researchers found that mRNA- and protein-based

On the left side of the image is the Falling Walls Science Summit logo; on the right is a portrait of Mark Brönstrup.
© Falling Walls Science Summit, HZI/Verena Meier

DZIF project nominated for the “Science Breakthrough of the Year 2026” award

The project “PROTON—Breaking the Wall of Deadly Bacterial Infections” has been nominated by the Falling Walls Foundation for the title “Science Breakthrough of the Year 2026” in the Life Sciences

Computer-generated image of a phage attached to the surface of a bacterial cell and injecting its DNA into the cell.
© Matthieu Louis/stock.adobe.com

Viruses against bacteria: EU funds phage therapy with €15 million

Bacteria are becoming increasingly resistant to antibiotics. One alternative is treatment with viruses that exclusively infect bacteria, known as phages. A research project funded by the European

Red-coloured rod-shaped bacteria in an electron micrograph.
© CDC/Alissa Eckert; James Archer

New genomic test reveals hidden drug-resistant tuberculosis in Eswatini

Researchers in Eswatini, in collaboration with an international consortium, have made a significant breakthrough in tuberculosis (TB) diagnostics. Using targeted genome sequencing, they detected drug

Treatment of a patient during the clinical study of SPAP in Gabon
© Ghyslain Mombo-Ngoma

Promising single-dose malaria treatment advances toward pan-African clinical trial

Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for

Multicolor fluorescence microscopy image of a cell infected with Ebola viruses.
© BNITM/Lina Widerspick

Hiding in the central nervous system: using cerebral organoids to better understand Ebola virus biology

Following infection, the Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system. The danger is

A cloved hand is taking a swab sample from the tongue in an open mouth
© RioPatuca Images/stock.adobe.com

A single swab is all it takes: Study paves the way for easier tuberculosis detection

An international research team led by scientists from Heidelberg University’s Faculty of Medicine and the University of California, San Francisco (USA), has investigated a new method for diagnosing

US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)

With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the